3,130 KRW
18.91 B KRW
292.13 B KRW
5.81 M
About SAMJIN PHARMACEUTICAL
Sector
CEO
Yong-Ju Choi
Headquarters
Seoul
Website
Founded
1968
ISIN
KR7005500004
FIGI
BBG000BDVF73
Samjin Pharmaceutical Co., Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. Its products include tablets, capsules, and shots. The company was founded on April 18, 1968 and is headquartered in Seoul, South Korea.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 005500 is 18,100 KRW — it has decreased by −1.84% in the past 24 hours. Watch SAMJIN PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SAMJIN PHARMACEUTICAL stocks are traded under the ticker 005500.
005500 stock has risen by 1.75% compared to the previous week, the month change is a −2.05% fall, over the last year SAMJIN PHARMACEUTICAL has showed a −15.42% decrease.
We've gathered analysts' opinions on SAMJIN PHARMACEUTICAL future price: according to them, 005500 price has a max estimate of 24,000.00 KRW and a min estimate of 24,000.00 KRW. Watch 005500 chart and read a more detailed SAMJIN PHARMACEUTICAL stock forecast: see what analysts think of SAMJIN PHARMACEUTICAL and suggest that you do with its stocks.
005500 reached its all-time high on Sep 28, 2018 with the price of 64,900 KRW, and its all-time low was 3,490 KRW and was reached on May 18, 2004. View more price dynamics on 005500 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
005500 stock is 4.43% volatile and has beta coefficient of 0.68. Track SAMJIN PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is SAMJIN PHARMACEUTICAL there?
Today SAMJIN PHARMACEUTICAL has the market capitalization of 237.77 B, it has increased by 3.49% over the last week.
Yes, you can track SAMJIN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
005500 net income for the last quarter is 4.49 B KRW, while the quarter before that showed 24.79 B KRW of net income which accounts for −81.88% change. Track more SAMJIN PHARMACEUTICAL financial stats to get the full picture.
Yes, 005500 dividends are paid annually. The last dividend per share was 800.00 KRW. As of today, Dividend Yield (TTM)% is 4.21%. Tracking SAMJIN PHARMACEUTICAL dividends might help you take more informed decisions.
SAMJIN PHARMACEUTICAL dividend yield was 3.70% in 2023, and payout ratio reached 54.81%. The year before the numbers were 3.12% and 46.30% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has 781.00 employees. See our rating of the largest employees — is SAMJIN PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAMJIN PHARMACEUTICAL EBITDA is 46.10 B KRW, and current EBITDA margin is 12.36%. See more stats in SAMJIN PHARMACEUTICAL financial statements.
Like other stocks, 005500 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAMJIN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAMJIN PHARMACEUTICAL technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAMJIN PHARMACEUTICAL stock shows the sell signal. See more of SAMJIN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.